Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Alan D Michelson

Showing results (71-80 of 124) with videos related to

Pageof 13
Sort By:
Thrombosis and Haemostasis|June 27, 2002
An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregatesStanley J Marciniak, Mary A Mascelli, Mark I Furman, et al.
Blood|July 4, 2015
Platelet function tests, independent of platelet count, are associated with bleeding severity in ITPAndrew L Frelinger, Rachael F Grace, Anja J Gerrits, et al.
Plos One|April 12, 2014
Antiplatelet activity, P2Y₁ and P2Y₁₂ inhibition, and metabolism in plasma of stereoisomers of diadenosine 5',5'″-P¹ ,P⁴-dithio-P²,P³-chloromethylenetetraphosphateHung Chang, Ivan B Yanachkov, Edward J Dix, et al.
Journal of the American College of Cardiology|April 3, 2012
A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteersAndrew L Frelinger, Ronald D Lee, Darcy J Mulford, et al.
The Journal of Trauma and Acute Care Surgery|August 28, 2014
Platelet activation using electric pulse stimulation: growth factor profile and clinical implicationsAndrew S Torres, Antonio Caiafa, Allen L Garner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 9, 2016
Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated ThrombosisThomas Gremmel, Ivan B Yanachkov, Milka I Yanachkova, et al.
Blood|February 2, 2012
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activationBethan Psaila, James B Bussel, Matthew D Linden, et al.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2021
Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: Communication from the ISTH SSC Subcommittee on Platelet PhysiologyAndrew L Frelinger, José Rivera, David E Connor, et al.
Platelets|March 9, 2013
Platelet activation and inhibition in sickle cell disease (pains) studyAndrew L Frelinger, Joseph A Jakubowski, Julie K Brooks, et al.
Contemporary Clinical Trials|August 26, 2019
Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)Matthew M Heeney, Miguel R Abboud, Carl Amilon, et al.
Pageof 13

Showing results (71-80 of 124) with videos related to

Sort By:
Pageof 13
Thrombosis and Haemostasis|June 27, 2002
An additional mechanism of action of abciximab: dispersal of newly formed platelet aggregatesStanley J Marciniak, Mary A Mascelli, Mark I Furman, et al.
Blood|July 4, 2015
Platelet function tests, independent of platelet count, are associated with bleeding severity in ITPAndrew L Frelinger, Rachael F Grace, Anja J Gerrits, et al.
Plos One|April 12, 2014
Antiplatelet activity, P2Y₁ and P2Y₁₂ inhibition, and metabolism in plasma of stereoisomers of diadenosine 5',5'″-P¹ ,P⁴-dithio-P²,P³-chloromethylenetetraphosphateHung Chang, Ivan B Yanachkov, Edward J Dix, et al.
Journal of the American College of Cardiology|April 3, 2012
A randomized, 2-period, crossover design study to assess the effects of dexlansoprazole, lansoprazole, esomeprazole, and omeprazole on the steady-state pharmacokinetics and pharmacodynamics of clopidogrel in healthy volunteersAndrew L Frelinger, Ronald D Lee, Darcy J Mulford, et al.
The Journal of Trauma and Acute Care Surgery|August 28, 2014
Platelet activation using electric pulse stimulation: growth factor profile and clinical implicationsAndrew S Torres, Antonio Caiafa, Allen L Garner, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|January 9, 2016
Synergistic Inhibition of Both P2Y1 and P2Y12 Adenosine Diphosphate Receptors As Novel Approach to Rapidly Attenuate Platelet-Mediated ThrombosisThomas Gremmel, Ivan B Yanachkov, Milka I Yanachkova, et al.
Blood|February 2, 2012
In vivo effects of eltrombopag on platelet function in immune thrombocytopenia: no evidence of platelet activationBethan Psaila, James B Bussel, Matthew D Linden, et al.
Journal of Thrombosis and Haemostasis : JTH|September 28, 2021
Consensus recommendations on flow cytometry for the assessment of inherited and acquired disorders of platelet number and function: Communication from the ISTH SSC Subcommittee on Platelet PhysiologyAndrew L Frelinger, José Rivera, David E Connor, et al.
Platelets|March 9, 2013
Platelet activation and inhibition in sickle cell disease (pains) studyAndrew L Frelinger, Joseph A Jakubowski, Julie K Brooks, et al.
Contemporary Clinical Trials|August 26, 2019
Ticagrelor versus placebo for the reduction of vaso-occlusive crises in pediatric sickle cell disease: Rationale and design of a randomized, double-blind, parallel-group, multicenter phase 3 study (HESTIA3)Matthew M Heeney, Miguel R Abboud, Carl Amilon, et al.
Pageof 13